2.

I del 3 ska tabell 3.1 ändras på följande sätt: a) Rubriken till andra kolumnen ska ersättas med följande: ”Kemiskt namn”. b) Rubriken till näst sista kolumnen ska ersättas med följande: ”Särskilda koncentrationsgränser, M-faktorer och uppskattad akut toxicitet (ATE) (*). (*) ATE för oral och dermal exponering uttrycks som mg/kg bw, som står för milligram per kilogram kroppsvikt.” c) Posten för indexnummer 607-414-00-6 ska utgå. d) Posterna för indexnumren 006-044-00-7, 015-101-00-5, 016-096-00-2, 017-011-00-1, 025-002-00-9, 603-180-00-4, 604-014-00-3, 604-016-00-4, 604-090-00-8, 605-003-00-6, 606-047-009, 607-096-00-9, 607-103-00-5, 607-113-00-X, 607-373-00-4, 613-167-00-5, 613-205-00-0 och 614-001-00-4 ska ersättas med följande poster: Index nr Kemiskt namn EG-nr CAS-nr Klassificering Märkning Särskilda koncentrationsgränser, M-faktorer och uppskattad akut toxicitet (ATE) Anm.: Faroklass och farokategorikod(er) Faroangivelse kod(er) Piktogram, signalordskod(er) Faroangivelse kod(er) Kompl. faroangivelse kod(er) ”006-044-00-7 isoproturon [ISO] 3-(4-isopropylfenyl)-1,1-dimetylurea 251-835-4 34123-59-6 Carc. 2 STOT RE 2 Aquatic Acute 1 Aquatic Chronic 1 H351 H373 (blod) H400 H410 GHS08 GHS09 Wng H351 H373 (blod) H410 M = 10 M = 10” ”015-101-00-5 fosmet (ISO); S-[(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)metyl]-O,O-dimetyl fosforditioat; O,O-dimetyl-S-ftalimidometylfosforditioat 211-987-4 732-11-6 Repr. 2 Acute Tox. 4 Acute Tox. 3 STOT SE 1 Aquatic Acute 1 Aquatic Chronic 1 H361f H332 H301 H370 (nervsystem) H400 H410 GHS08 GHS06 GHS09 Dgr H361f H332 H301 H370 (nervsystem) H410 M = 100 M = 100” ”016-096-00-2 tifensulfuronmetyl (ISO) metyl-3-(4-metoxi-6-metyl-1,3,5-triazin-2-ylkarbamoylsulfamoyl)tiofen-2-karboxylat — 79277-27-3 Aquatic Acute 1 Aquatic Chronic 1 H400 H410 GHS09 Wng H410 M = 100 M = 100” ”017-011-00-1 natriumhypoklorit, lösning … % aktivt klor 231-668-3 7681-52-9 Skin Corr. 1B Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 H314 H318 H400 H410 GHS05 GHS09 Dgr H314 H410 EUH031 M = 10 M = 1 EUH031: C ≥ 5 % B” ”025-002-00-9 kaliumpermanganat 231-760-3 7722-64-7 Ox. Sol. 2 Repr. 2 Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 H272 H361d H302 H400 H410 GHS03 GHS08 GHS07 GHS09 Dgr H272 H361d H302 H410” ”603-180-00-4 kolekalciferol; kolekalciferol; vitamin D3 200-673-2 67-97-0 Acute Tox. 2 Acute Tox. 2 Acute Tox. 2 STOT RE 1 H330 H310 H300 H372 GHS06 GHS08 Dgr H330 H310 H300 H372 inhalation: ATE = 0,05 mg/l (damm eller dimma) dermal: ATE = 50 mg/kg bw oral: ATE = 35 mg/kg bw STOT RE 1; H372: C ≥ 3 % STOT RE 2; H373: 0,3 % ≤ C < 3 %” ”604-014-00-3 klorkresol; 4-klor-m-kresol; 4-klor-3-metylfenol 200-431-6 59-50-7 Acute Tox. 4 Skin Corr. 1C Eye Dam. 1 STOT SE 3 Skin Sens. 1B Aquatic Acute 1 Aquatic Chronic 3 H302 H314 H318 H335 H317 H400 H412 GHS07 GHS05 GHS09 Dgr H302 H314 H335 H317 H410 M = 1” ”604-016-00-4 1,2-dihydroxibensen; pyrokatekol 204-427-5 120-80-9 Carc. 1Β Muta. 2 Acute Tox. 3 Acute Tox. 3 Skin Irrit. 2 Eye Irrit. 2 H350 H341 H311 H301 H315 H319 GHS08 GHS06 Dgr H350 H341 H311 H301 H315 H319 oral: ATE = 300 mg/kg bw dermal: ATE = 600 mg/kg bw” ”604-090-00-8 4-tert-butylfenol 202-679-0 98-54-4 Repr. 2 Skin Irrit. 2 Eye Dam. 1 Aquatic Chronic 1 H361f H315 H318 H410 GHS08 GHS05 GHS09 Dgr H361f H315 H318 H410 M = 1” ”605-003-00-6 acetaldehyd; etanal 200-836-8 75-07-0 Flam. Liq. 1 Carc. 1B Muta. 2 STOT SE 3 Eye Irrit. 2 H224 H350 H341 H335 H319 GHS02 GHS08 GHS07 Dgr H224 H350 H341 H335 H319” ”606-047-00-9 2-bensyl-2-dimetylamino-4′-morfolinobutyrofenon 404-360-3 119313-12-1 Repr. 1B Aquatic Acute 1 Aquatic Chronic 1 H360D H400 H410 GHS08 GHS09 Dgr H360D H410” ”607-096-00-9 maleinsyraanhydrid 203-571-6 108-31-6 Acute Tox. 4 STOT RE 1 Skin Corr. 1B Eye Dam. 1 Resp. Sens. 1 Skin Sens. 1A H302 H372 (luftvägar) (inhalation) H314 H318 H334 H317 GHS07 GHS08 GHS05 Dgr H302 H372 (luftvägar) (inhalation) H314 H334 H317 EUH071 Skin Sens. 1A; H317: C ≥ 0,001 %” ”607-103-00-5 bärnstenssyraanhydrid 203-570-0 108-30-5 Acute Tox. 4 Skin Corr. 1 Eye Dam. 1 Resp. Sens. 1 Skin Sens. 1 H302 H314 H318 H334 H317 GHS07 GHS05 GHS08 Dgr H302 H314 H334 H317 EUH071” ”607-113-00-X isobutylmetakrylat 202-613-0 97-86-9 Flam. Liq. 3 STOT SE 3 Skin Irrit. 2 Skin Sens. 1B H226 H335 H315 H317 GHS02 GHS07 Wng H226 H335 H315 H317 D” ”607-373-00-4 kizalofop-P-tefuryl (ISO) (+/–) tetrahydrofurfuryl-(R)-2-[4-(6-klorkinoxalin-2-yloxi)fenyloxi]propionat 414-200-4 200509-41-7 Carc. 2 Repr. 2 Acute Tox. 4 STOT RE 2 Aquatic Acute 1 Aquatic Chronic 1 H351 H361fd H302 H373 H400 H410 GHS08 GHS07 GHS09 Wng H351 H361fd H302 H373 H410 M = 1 M = 1” ”613-167-00-5 reaktionsblandning av 5-klor-2-metyl-2H-isotiazol-3-on och 2-metyl-2H-isotiazol-3-on (3:1) — 55965-84-9 Acute Tox. 2 Acute Tox. 2 Acute Tox. 3 Skin Corr. 1C Eye Dam. 1 Skin Sens. 1A Aquatic Acute 1 Aquatic Chronic 1 H330 H310 H301 H314 H318 H317 H400 H410 GHS06 GHS05 GHS09 Dgr H330 H310 H301 H314 H317 H410 EUH071 Skin Corr. 1C; H314: C ≥ 0,6 % Skin Irrit. 2; H315: 0,06 % ≤ C < 0,6 % Eye Dam. 1; H318: C ≥ 0,6 % Eye Irrit. 2; H319: 0,06 % ≤ C < 0,6 % Skin Sens. 1A; H317: C ≥ 0,0015 % M = 100 M = 100 B” ”613-205-00-0 propikonazol (ISO); (2RS,4RS;2RS,4SR)-1-{[2-(2,4-diklorfenyl)-4-propyl-1,3-dioxolan-2-yl]metyl}-1H-1,2,4-triazol 262-104-4 60207-90-1 Repr. 1B Acute Tox. 4 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H360D H302 H317 H400 H410 GHS08 GHS07 GHS09 Dgr H360D H302 H317 H410 M = 1 M = 1” ”614-001-00-4 nikotin (ISO); 3-[(2S)-1-metylpyrrolidin-2-yl]pyridin 200-193-3 54-11-5 Acute Tox. 2 Acute Tox. 2 Acute Tox. 2 Aquatic Chronic 2 H330 H310 H300 H411 GHS06 GHS09 Dgr H330 H310 H300 H411 inhalation: ATE = 0,19 mg/l (damm eller dimma) dermal: ATE = 70 mg/kg bw oral: ATE = 5 mg/kg bw” e) Följande poster ska införas på lämplig plats i samma ordningsföljd som för posterna i tabell 3.1: Index nr Kemiskt namn EG-nr CAS-nr Klassificering Märkning Särskilda koncentrationsgränser, M-faktorer och uppskattad akut toxicitet (ATE) Anm.: Faroklass och farokategorikod(er) Faroangivelse kod(er) Piktogram, signalordskod(er) Faroangivelse kod(er) Kompl. faroangivelse kod(er) ”604-094-00-X isoeugenol [1] (E)-2-metoxi-4-(prop-1-enyl)fenol; [2] (Z)-2-metoxi-4-(prop-1-enyl)fenol [3] 202-590-7 [1] 227-678-2 [2] 227-633-7 [3] 97-54-1 [1] 5932-68-3 [2] 5912-86-7 [3] Skin Sens. 1A H317 GHS07 Wng H317 Skin Sens. 1A; H317: C ≥ 0,01 %” ”607-724-00-1 2,3,5,6-tetrafluor-4-(metoximetyl)bensyl(1R,3R)-2,2-dimetyl-3-[(1Z)-prop-1-en-1-yl]cyklopropankarboxylat; epsilon-metoflutrin — 240494-71-7 Acute Tox. 4 Acute Tox. 3 STOT SE 1 STOT RE 2 Aquatic Acute 1 Aquatic Chronic 1 H332 H301 H370 (nervsystem) H373 H400 H410 GHS06 GHS08 GHS09 Dgr H332 H301 H370 (nervsystem) H373 H410 M = 100 M = 100” ”607-725-00-7 isopropyl (2E,4E,7S)-11-metoxi-3,7,11-trimetyldodeka-2,4-dienoat; S-metopren — 65733-16-6 Aquatic Acute 1 Aquatic Chronic 1 H400 H410 GHS09 Wng H410 M = 1 M = 1” ”607-726-00-2 pinoxaden (ISO); 8-(2,6-dietyl-4-metylfenyl)-7-oxo-1,2,4,5-tetrahydro-7H-pyrazolo[1,2-d][1,4,5]oxadiazepin-9-yl 2,2-dimetylpropanoat — 243973-20-8 Repr. 2 Acute Tox. 4 Acute Tox. 4 Eye Irrit. 2 STOT SE 3 Skin Sens. 1A Aquatic Acute 1 Aquatic Chronic 3 H361d H332 H302 H319 H335 H317 H400 H412 GHS08 GHS07 GHS09 Wng H361d H332 H302 H319 H335 H317 H410 inhalation: ATE = 4,63 mg/l (damm eller dimma) oral: ATE = 500 mg/kg bw M = 1” ”607-727-00-8 tetrametrin (ISO); (1,3-dioxo-1,3,4,5,6,7-hexahydro-2H-isoindol-2-yl)metyl-2,2-dimetyl-3-(2-metylprop-1-en-1-yl)cyklopropankarboxylat 231-711-6 7696-12-0 Carc. 2 Acute Tox. 4 STOT SE 2 Aquatic Acute 1 Aquatic Chronic 1 H351 H302 H371 (nervsystem) (inhalation) H400 H410 GHS08 GHS07 GHS09 Wng H351 H302 H371 (nervsystem) (inhalation) H410 M = 100 M = 100” ”607-728-00-3 (1,3,4,5,6,7-hexahydro-1,3-dioxo-2H-isoindol-2-yl)metyl(1R-trans)-2,2-dimetyl-3-(2-metylprop-1-enyl)cyklopropankarboxylat 214-619-0 1166-46-7 Carc. 2 Acute Tox. 4 STOT SE 2 Aquatic Acute 1 Aquatic Chronic 1 H351 H302 H371 (nervsystem) (inhalation) H400 H410 GHS08 GHS07 GHS09 Wng H351 H302 H371 (nervsystem) (inhalation) H410 M = 100 M = 100” ”607-729-00-9 metsulfuronmetyl (ISO); metyl-2-[(4,6-dimetoxipyrimidin-2-ylkarbamoyl)sulfamoyl]-α-(metansulfonamid)-p-toluat; — 208465-21-8 Aquatic Acute 1 Aquatic Chronic 1 H400 H410 GHS09 Wng H410 M = 100 M = 100” ”607-730-00-4 spirodiklofen (ISO); 3-(2,4-diklorfenyl)-2-oxo-1-oxaspiro[4.5]deka-3-en-4-yl-2,2-dimetylbutyrat — 148477-71-8 Carc. 1B Repr. 2 STOT RE 2 Skin Sens. 1B Aquatic Chronic 1 H350 H361f H373 H317 H410 GHS08 GHS07 GHS09 Dgr H350 H361f H373 H317 H410 M = 10” ”607-731-00-X natriummetyl[(4-aminofenyl)sulfonyl]karbamat; natriummetyl(EZ)sulfanilylkarbonimidat; asulamnatrium 218-953-8 2302-17-2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H317 H400 H410 GHS07 GHS09 Wng H317 H410 M = 1 M = 1” ”607-732-00-5 salicylsyra 200-712-3 69-72-7 Repr. 2 Acute Tox. 4 Eye Dam. 1 H361d H302 H318 GHS08 GHS07 GHS05 Dgr H361d H302 H318” ”608-068-00-9 flutianil (ISO); (2Z)-{[2-fluor-5-(trifluormetyl)fenyl]tio}[3-(2-metoxifenyl)-1,3-tiazolidin-2-yliden]acetonitril — 958647-10-4 Aquatic Chronic 1 H410 GHS09 Wng H410 M = 100” ”612-293-00-8 reaktionsblandning av 1-[2-(2-aminobutoxi)etoxi]but-2-ylamin och 1-({[2-(2-aminobutoxi)etoxi]metyl}propoxi)but-2-ylamin 447-920-2 — Repr. 2 Acute Tox. 4 Skin Corr. 1B Eye Dam. 1 H361f H302 H314 H318 GHS08 GHS07 GHS05 Dgr H361f H302 H314 EUH071” ”613-326-00-9 2-metylisotiazol-3(2H)-on 220-239-6 2682-20-4 Acute Tox. 2 Acute Tox. 3 Acute Tox. 3 Skin Corr. 1B Eye Dam. 1 Skin Sens. 1A Aquatic Acute 1 Aquatic Chronic 1 H330 H311 H301 H314 H318 H317 H400 H410 GHS05 GHS06 GHS09 Dgr H330 H311 H301 H314 H317 H410 EUH071 Skin Sens. 1A; H317: C ≥ 0,0015 % M = 10 M = 1” ”613-327-00-4 pyroxsulam (ISO); N-(5,7-dimetoxi[1,2,4]triazolo[1,5-a]pyrimidin-2-yl)-2-metoxi-4-(trifluormetyl)pyridin-3-sulfonamid — 422556-08-9 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H317 H400 H410 GHS07 GHS09 Wng H317 H410 M = 100 M = 100” ”613-328-00-X 1-vinylimidazol 214-012-0 1072-63-5 Repr. 1B H360D GHS08 Dgr H360D Repr. 1B; H360D: C ≥ 0,03 %” ”616-224-00-2 amisulbrom (ISO); 3-(3-brom-6-fluor-2-metylindol-1-ylsulfonyl)-N,N-dimetyl-1H-1,2,4-triazol-1-sulfonamid — 348635-87-0 Carc. 2 Eye Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 H351 H319 H400 H410 GHS08 GHS07 GHS09 Wng H351 H319 H410 M = 10 M = 10”